{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:57:04Z","timestamp":1776347824613,"version":"3.51.2"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The special fund for science and technology development guided by the central government for local areas"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03243-4","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:44:01Z","timestamp":1773657841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel matrine derivative exerts antitumor effects against hepatocellular carcinoma by inducing oxidative stress and DNA damage"],"prefix":"10.1007","volume":"43","author":[{"given":"Zhouxing","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"9","key":"3243_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000019282","volume":"99","author":"W Li","year":"2020","unstructured":"Li W, Wu C, Qin M, Cai F, Huang J. The aura of malignant tumor: clinical analysis of malignant tumor-related pyogenic liver abscess. Med. 2020;99(9):e19282. https:\/\/doi.org\/10.1097\/md.0000000000019282.","journal-title":"Med"},{"key":"3243_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1593960","volume":"16","author":"MA Youssef","year":"2025","unstructured":"Youssef MA, Al-Sharif H, McGrath BT, Picken MM, Le Poole IC. Benign tumors broaden the field of application for immunotherapy. Front Immunol. 2025;16:1593960. https:\/\/doi.org\/10.3389\/fimmu.2025.1593960.","journal-title":"Front Immunol"},{"key":"3243_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph22060933","author":"L Zhang","year":"2025","unstructured":"Zhang L, Muscat JE. Trends in malignant and benign brain tumor incidence and mobile phone use in the U.S. (2000\u20132021): a SEER-based study. Int J Environ Res Public Health. 2025. https:\/\/doi.org\/10.3390\/ijerph22060933.","journal-title":"Int J Environ Res Public Health"},{"key":"3243_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1011435","volume":"10","author":"G Sufianova","year":"2022","unstructured":"Sufianova G, Gareev I, Beylerli O, Wu J, Shumadalova A, Sufianov A, et al. Modern aspects of the use of natural polyphenols in tumor prevention and therapy. Front Cell Dev Biol. 2022;10:1011435. https:\/\/doi.org\/10.3389\/fcell.2022.1011435.","journal-title":"Front Cell Dev Biol"},{"key":"3243_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.977374","volume":"16","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xu L, Cai Q, Wang M, Wang X, Wang S, et al. Research progress on the pharmacological effects of matrine. Front Neurosci. 2022;16:977374. https:\/\/doi.org\/10.3389\/fnins.2022.977374.","journal-title":"Front Neurosci"},{"key":"3243_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103209","author":"AM Zimmermann-Klemd","year":"2022","unstructured":"Zimmermann-Klemd AM, Reinhardt JK, Winker M, Gr\u00fcndemann C. Phytotherapy in integrative oncology-an update of promising treatment options. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27103209.","journal-title":"Molecules"},{"key":"3243_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126313","volume":"252","author":"X Huang","year":"2023","unstructured":"Huang X, Li S, Ding R, Li Y, Li C, Gu R. Antitumor effects of polysaccharides from medicinal lower plants: a review. Int J Biol Macromol. 2023;252:126313. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126313.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3243_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1381612826666191230142638","volume":"26","author":"S Munir","year":"2020","unstructured":"Munir S, Shah AA, Shahid M, Ahmed MS, Shahid A, Rajoka MSR, et al. Anti-angiogenesis potential of phytochemicals for the therapeutic management of tumors. Curr Pharm Des. 2020;26(2):265\u201378. https:\/\/doi.org\/10.2174\/1381612826666191230142638.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"3243_CR9","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1021\/acs.jmedchem.4c03203","volume":"68","author":"CC Chang","year":"2025","unstructured":"Chang CC, Li HJ, Satange R, Lin SM, Chen TL, Lin CC, et al. Structural and functional insights into targeting GCCG sites in the EGFR promoter by two DNA intercalators to inhibit breast cancer metastasis. J Med Chem. 2025;68(6):6601\u201315. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c03203.","journal-title":"J Med Chem"},{"issue":"1","key":"3243_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201800141","volume":"41","author":"KV Gurova","year":"2019","unstructured":"Gurova KV. Chromatin stability as a target for cancer treatment. Bioessays. 2019;41(1):e1800141. https:\/\/doi.org\/10.1002\/bies.201800141.","journal-title":"Bioessays"},{"key":"3243_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cancergen.2020.12.002","volume":"252","author":"LC de Almeida","year":"2021","unstructured":"de Almeida LC, Calil FA, Machado-Neto JA, Costa-Lotufo LV. DNA damaging agents and DNA repair: from carcinogenesis to cancer therapy. Cancer Genet. 2021;252:6\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2020.12.002.","journal-title":"Cancer Genet"},{"issue":"6","key":"3243_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2174\/1871520622666220822010953","volume":"23","author":"Z Lian","year":"2023","unstructured":"Lian Z, Tai Y, Xia H, Zhai H. QSAR study of novel 1, 8-naphthimide derivatives targeting nuclear DNA. Anticancer Agents Med Chem. 2023;23(6):726\u201333. https:\/\/doi.org\/10.2174\/1871520622666220822010953.","journal-title":"Anticancer Agents Med Chem"},{"key":"3243_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109058","volume":"166","author":"NK Hasan","year":"2025","unstructured":"Hasan NK, Mahmoud Z, Kandeel MM, Soliman AAF, El-Khouly EA. Novel 2,6-Bis(indolyl\/ 5-bromoindolyl)dihydropyridine\/pyridine hybrids as potential anti-tumor agents: design, one-pot green synthesis, molecular docking, and cytotoxicity evaluation. Bioorg Chem. 2025;166:109058. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109058.","journal-title":"Bioorg Chem"},{"key":"3243_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118157","volume":"300","author":"C Gao","year":"2025","unstructured":"Gao C, Wang W, Yu Y, Wu J. Design, synthesis, and biological evaluation of phenylsulfonylfuroxan-\u03b2-carboline-hydroxamic acid ternary hybrids for cancer. Eur J Med Chem. 2025;300:118157. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118157.","journal-title":"Eur J Med Chem"},{"issue":"6","key":"3243_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70154","volume":"86","author":"R Dubey","year":"2025","unstructured":"Dubey R, Gupta S, Singh R, Chandel S, Thakur S, Irani M, et al. Triazole-pyrimidine hybrids as EGFR inhibitors via synthesis, in silico, in vitro, and in vivo evaluation as anticancer agents. Drug Dev Res. 2025;86(6):e70154. https:\/\/doi.org\/10.1002\/ddr.70154.","journal-title":"Drug Dev Res"},{"issue":"27","key":"3243_CR16","doi-asserted-by":"publisher","first-page":"15836","DOI":"10.1039\/d0ra01822h","volume":"10","author":"P Shalini","year":"2020","unstructured":"Shalini P, Saha ST, Kaur M, Oluwakemi E, Awolade P, et al. Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone\/pyrazoline conjugates as potential serms with computational validation. RSC Adv. 2020;10(27):15836\u201345. https:\/\/doi.org\/10.1039\/d0ra01822h.","journal-title":"RSC Adv"},{"key":"3243_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.semcancer.2021.04.012","volume":"85","author":"JA Kloeber","year":"2022","unstructured":"Kloeber JA, Lou Z. Critical DNA damaging pathways in tumorigenesis. Semin Cancer Biol. 2022;85:164\u201384. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.012.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3243_CR18","doi-asserted-by":"publisher","first-page":"21674","DOI":"10.1038\/s41598-020-78766-5","volume":"10","author":"AG Souza","year":"2020","unstructured":"Souza AG, Bastos VAF, Fujimura PT, Ferreira ICC, Leal LF, da Silva LS, et al. Cell-free DNA promotes malignant transformation in non-tumor cells. Sci Rep. 2020;10(1):21674. https:\/\/doi.org\/10.1038\/s41598-020-78766-5.","journal-title":"Sci Rep"},{"issue":"11","key":"3243_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100884","volume":"38","author":"A Papanicolau-Sengos","year":"2025","unstructured":"Papanicolau-Sengos A, Singh O, Park K, Snuderl M, Tretiakova M, Merino M, et al. DNA methylation-based classification of kidney neoplasms. Mod Pathol. 2025;100884. https:\/\/doi.org\/10.1016\/j.modpat.2025.100884.","journal-title":"Mod Pathol"},{"issue":"3","key":"3243_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ijc.34954","volume":"155","author":"D Pan","year":"2024","unstructured":"Pan D, Wang Q, Shen A, Qi Z, Zheng C, Hu B. When DNA damage responses meet tumor immunity: from mechanism to therapeutic opportunity. Int J Cancer. 2024;155(3):384\u201399. https:\/\/doi.org\/10.1002\/ijc.34954.","journal-title":"Int J Cancer"},{"issue":"3","key":"3243_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12010-018-2749-8","volume":"186","author":"U Yildiz","year":"2018","unstructured":"Yildiz U, Coban B. Novel naphthalimide derivatives as selective G-quadruplex DNA binders. Appl Biochem Biotechnol. 2018;186(3):547\u201362. https:\/\/doi.org\/10.1007\/s12010-018-2749-8.","journal-title":"Appl Biochem Biotechnol"},{"key":"3243_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231225861","volume":"23","author":"HY Zhang","year":"2024","unstructured":"Zhang HY, Han LL, Wu HY, Xu XX, Yu MB, Chen GY, et al. Research progress on structure-activity relationship of 1,8-naphthalimide DNA chimeras against tumor. Technol Cancer Res Treat. 2024;23:15330338231225861. https:\/\/doi.org\/10.1177\/15330338231225861.","journal-title":"Technol Cancer Res Treat"},{"key":"3243_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2024.112721","volume":"261","author":"K Wang","year":"2024","unstructured":"Wang K, Wang L, Shang Z, Yang X, Li H, Wang X, et al. A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: synthesis, characterization and in vitro anticancer activity. J Inorg Biochem. 2024;261:112721. https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112721.","journal-title":"J Inorg Biochem"},{"issue":"11","key":"3243_CR24","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1021\/acsmedchemlett.3c00353","volume":"14","author":"C Ge","year":"2023","unstructured":"Ge C, Liu L, Wang Y, Di X, Luo X, Liu H, et al. Novel 1,8-naphthalimide derivatives as antitumor agents and potent demethylase inhibitors. ACS Med Chem Lett. 2023;14(11):1551\u20137. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00353.","journal-title":"ACS Med Chem Lett"},{"key":"3243_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29194529","author":"W Ruan","year":"2024","unstructured":"Ruan W, Xie Z, Wang Y, Xia L, Guo Y, Qiao D. An overview of naphthylimide as specific scaffold for new drug discovery. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29194529.","journal-title":"Molecules"},{"issue":"10","key":"3243_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/tcr.201600134","volume":"17","author":"R Tandon","year":"2017","unstructured":"Tandon R, Luxami V, Kaur H, Tandon N, Paul K. 1,8-naphthalimide: a potent DNA intercalator and target for cancer therapy. Chem Rec. 2017;17(10):956\u201393. https:\/\/doi.org\/10.1002\/tcr.201600134.","journal-title":"Chem Rec"},{"key":"3243_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109040","volume":"165","author":"G Shen","year":"2025","unstructured":"Shen G, Li S, Zhu Y, Xu Z, Liu X, Lv C, et al. Recent progress in topoisomerase inhibitors as anticancer agents: research and design strategies for Topo I and II inhibitors via structural optimization. Bioorg Chem. 2025;165:109040. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109040.","journal-title":"Bioorg Chem"},{"issue":"Pt 4","key":"3243_CR28","doi-asserted-by":"publisher","first-page":"125063","DOI":"10.1016\/j.ijbiomac.2023.125063","volume":"242","author":"X Zhan","year":"2023","unstructured":"Zhan X, Xu X, Zhang P, Wang X, Hu Z, Zhao W, et al. Crude polysaccharide from Danggui Buxue Decoction enhanced the anti-tumor effect of gemcitabine by remodeling tumor-associated macrophages. Int J Biol Macromol. 2023;242(Pt 4):125063. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125063.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3243_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115305","volume":"28","author":"Y Xu","year":"2020","unstructured":"Xu Y, Jing D, Zhao D, Wu Y, Xing L, Ur Rashid H, et al. New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment. Bioorg Med Chem. 2020;28(4):115305. https:\/\/doi.org\/10.1016\/j.bmc.2020.115305.","journal-title":"Bioorg Med Chem"},{"issue":"13","key":"3243_CR30","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.2174\/1389557522666220113124717","volume":"22","author":"J Xu","year":"2022","unstructured":"Xu J, Lv M, Xu H. The advances in bioactivities, mechanisms of action and structural optimizations of matrine and its derivatives. Mini-Rev Med Chem. 2022;22(13):1716\u201334. https:\/\/doi.org\/10.2174\/1389557522666220113124717.","journal-title":"Mini-Rev Med Chem"},{"key":"3243_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117130","volume":"177","author":"H Wang","year":"2024","unstructured":"Wang H, Wang X, Zhang Q, Liang Y, Wu H. Matrine reduces traumatic heterotopic ossification in mice by inhibiting M2 macrophage polarization through the MAPK pathway. Biomed Pharmacother. 2024;177:117130. https:\/\/doi.org\/10.1016\/j.biopha.2024.117130.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"3243_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02858-3","volume":"42","author":"A Ou","year":"2025","unstructured":"Ou A, Wang X, Xu T, Hu Z, Jiang L, Wang L. Design, synthesis and anti-tumor activity of matrine derivatives as Hsp90 inhibitors. Med Oncol. 2025;42(8):310. https:\/\/doi.org\/10.1007\/s12032-025-02858-3.","journal-title":"Med Oncol"},{"key":"3243_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116348","volume":"270","author":"G Qiu","year":"2024","unstructured":"Qiu G, Xie J, Li F, Han K, Long Q, Kowah JAH, et al. Design, synthesis and biological evaluation of matrine contains benzimidazole derivatives as dual TOPOI and PARP inhibitors for cancer therapy. Eur J Med Chem. 2024;270:116348. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116348.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3243_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6199-7","volume":"19","author":"Y Zou","year":"2019","unstructured":"Zou Y, Sarem M, Xiang S, Hu H, Xu W, Shastri VP. Autophagy inhibition enhances matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K\/Akt\/mTOR and Erk\/p38 signaling. BMC Cancer. 2019;19(1):949. https:\/\/doi.org\/10.1186\/s12885-019-6199-7.","journal-title":"BMC Cancer"},{"key":"3243_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/bmri\/6115993","volume":"2025","author":"N Korol","year":"2025","unstructured":"Korol N, Slyvka M, Rusyn I, Pallah O, Burmei S, Bestritska V. Design and enzyme-targeted assessment of 1,2,4-triazole-1,8-naphthalimide hybrids in drug discovery. Biomed Res Int. 2025;2025:6115993. https:\/\/doi.org\/10.1155\/bmri\/6115993.","journal-title":"Biomed Res Int"},{"key":"3243_CR36","doi-asserted-by":"publisher","first-page":"108815","DOI":"10.1016\/j.bioorg.2025.108815","volume":"164","author":"A Khanna","year":"2025","unstructured":"Khanna A, Narang A, Thakur V, Singh K, Kumar N, Kaur R, et al. Design, synthesis, antibacterial evaluation, and molecular modelling studies of 1,2,3-triazole-linked coumarin-vanillin hybrids as potential DNA gyrase and topoisomerase IV inhibitors. Bioorg Chem. 2025;164:108815. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108815.","journal-title":"Bioorg Chem"},{"key":"3243_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112951","volume":"210","author":"GB Liang","year":"2021","unstructured":"Liang GB, Wei JH, Jiang H, Huang RZ, Qin JT, Wang HL, et al. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA. Eur J Med Chem. 2021;210:112951. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112951.","journal-title":"Eur J Med Chem"},{"key":"3243_CR38","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00348b","author":"XQ Zhou","year":"2025","unstructured":"Zhou XQ, Huang YX, Liang QL, Huang RZ, Zhang Y, Lu HR, et al. A novel 1,8-naphthalimide-piperazine-amidobenzenesulfonamide derivative targets carbonic anhydrase IX to induce ferroptosis, apoptosis and autophagy in colorectal cancer cells. RSC Med Chem. 2025. https:\/\/doi.org\/10.1039\/d5md00348b.","journal-title":"RSC Med Chem"},{"key":"3243_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ejmech.2013.07.027","volume":"68","author":"M Verma","year":"2013","unstructured":"Verma M, Luxami V, Paul K. Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents. Eur J Med Chem. 2013;68:352\u201360. https:\/\/doi.org\/10.1016\/j.ejmech.2013.07.027.","journal-title":"Eur J Med Chem"},{"issue":"20","key":"3243_CR40","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1016\/j.bmcl.2018.09.008","volume":"28","author":"W Kong","year":"2018","unstructured":"Kong W, Bao Y, Ma Q, Xu H. Synthesis and biological activities of novel pyrazolomatrine derivatives. Bioorg Med Chem Lett. 2018;28(20):3338\u201341. https:\/\/doi.org\/10.1016\/j.bmcl.2018.09.008.","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"3243_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202501362","volume":"22","author":"S Asghar","year":"2025","unstructured":"Asghar S, Aziz A, Hameed S, Saeed BA, Allami RH, Al-Masoudi NA. Synthesis of novel 1,3,5-triazine analogues with selective activity against pancreatic (Capan-1) and colorectal (HCT-116) carcinomas: anticancer potential and DNA-binding affinity. Chem Biodivers. 2025;e01362. https:\/\/doi.org\/10.1002\/cbdv.202501362.","journal-title":"Chem Biodivers"},{"key":"3243_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105188","volume":"115","author":"SS Wang","year":"2021","unstructured":"Wang SS, Du SY, He X, Qi YM, Li XL, Rong RX, et al. Nucleus-targeting imaging and enhanced cytotoxicity based on naphthalimide derivatives. Bioorg Chem. 2021;115:105188. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105188.","journal-title":"Bioorg Chem"},{"key":"3243_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106505","volume":"135","author":"M Wang","year":"2023","unstructured":"Wang M, Li L, Yang S, Guo F, Zhu G, Zhu B, et al. Synthesis of novel oxazol-5-one derivatives containing chiral trifluoromethyl and isoxazole moieties as potent antitumor agents and the mechanism investigation. Bioorg Chem. 2023;135:106505. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106505.","journal-title":"Bioorg Chem"},{"issue":"7","key":"3243_CR44","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1016\/j.apsb.2025.05.008","volume":"15","author":"XJ Li","year":"2025","unstructured":"Li XJ, Huang KX, Wang KX, Liu R, Wang DC, Liang YR, et al. Design, synthesis, and antitumor activity of novel thioheterocyclic nucleoside derivatives by suppressing the c-MYC pathway. Acta Pharm Sin B. 2025;15(7):3685\u2013707. https:\/\/doi.org\/10.1016\/j.apsb.2025.05.008.","journal-title":"Acta Pharm Sin B"},{"key":"3243_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107457","volume":"148","author":"L Han","year":"2024","unstructured":"Han L, Tan H, Lee J, Wang P, Zhao Y. Synthesis of triazole AD-1 derivatives and its mechanism of mediating DNA damage of ROS in lung cancer cells. Bioorg Chem. 2024;148:107457. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107457.","journal-title":"Bioorg Chem"},{"issue":"1","key":"3243_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-09168-8","volume":"15","author":"L Wang","year":"2025","unstructured":"Wang L, Hou X, Huang M, He B, Mao L, Hu Z, et al. Design, synthesis and anti-cancer activity of novel 1,2,3-triazole hybrids of erlotinib against cervical cancer via MAPK signaling pathway. Sci Rep. 2025;15(1):24582. https:\/\/doi.org\/10.1038\/s41598-025-09168-8.","journal-title":"Sci Rep"},{"key":"3243_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29225438","author":"J Wu","year":"2024","unstructured":"Wu J, Huang X, Lu S, Wang Z, Mao L, Li S. Synthesis of novel gefitinib-conjugated 1,2,3-triazole derivatives and their effect of inducing DNA damage and apoptosis in tumor cells. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29225438.","journal-title":"Molecules"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03243-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:06:50Z","timestamp":1776344810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03243-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03243-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}